Efficacy and Safety of First-line Single-Agent Carboplatin vs Carboplatin Plus Paclitaxel for Vulnerable Older Adult Women With Ovarian Cancer. A GINECO/GCIG Randomized Clinical Trial - Falandry, C (JAMA Oncol, 2021)